Emergent BioSolutions, Inc. (EBS)
7.85
-0.25
(-3.09%)
USD |
NYSE |
Apr 07, 16:00
7.86
+0.01
(+0.13%)
After-Hours: 20:00
Emergent BioSolutions SG&A Expense (TTM) : 186.10M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 6.888B |
| Eli Lilly & Co. | 11.09B |
| Penumbra, Inc. | 663.42M |
| Disc Medicine, Inc. | 65.38M |
| MetaVia, Inc. | 6.906M |